
The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy
Keywords: Head and neck cancer; PARP; ABT-888; EGFR; Biomarker; H2AX; DNA damage; Nuclear import; DNA repair; Non-homologous end-joining (NHEJ); Radiation;